Stroke from artery narrowing: testing combination of anti-platelet drugs
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a combination of two or three anti-platelet medicines (like aspirin, clopidogrel, or cilostazol) is safe and works better than one alone for people who had a stroke from a narrowed artery. The goal is to prevent another stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 20 years or older.
- You had a stroke caused by a narrowed artery in your neck or brain (large artery atherosclerosis).
- You can agree to join the study within 3 days of the stroke.
- You do not have bleeding in the brain or need long-term blood thinners for other reasons.
- You are not allergic to aspirin, clopidogrel, or cilostazol.
- If you could become pregnant, you agree to use birth control or avoid pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This study tests whether a combination of two blood-thinning medications (clopidogrel and rivaroxaban) is better than standard treatment (aspirin alone or aspirin plus clopidogrel) for preventing another stroke in people who have a narrowed artery inside the brain. It aims to reduce the risk of future strokes while managing bleeding risks.
This study compares two common blood-thinner combinations to see which one works better at preventing clots during stent placement for an unruptured brain aneurysm. It is designed for people whose bodies process these medications normally, with the goal of finding the safest and most effective option.
This trial tests whether placing a stent in a severely narrowed brain artery, along with aggressive medication, can prevent another stroke better than medication alone. It is for people who had a mild stroke within the last 30 days due to a 70-99% blockage in a major brain artery.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Hear when a new Cerebral Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.